Extended surface aggregates in the treatment of skin conditions
EA010407B1
Pharmaceutical preparations for improved transport through semi-permeable barriers and for none-invasive drug application in vivo
US7473432B2
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
CA2377422A1
Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof
MXPA02000053A
A method for the improvement of transport across adaptable semi-permeable barriers.
EP1031346A1
Noninvasive vaccination through the skin
EP1031347A1
Transnasal transport/immunisation with highly adaptable carriers
KR20060088906A
Improved formulation for topical non-invasive application in vivo
EP1140021A1
Improved formulation for topical non-invasive application in vivo
HU0102741A2
Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
RU2211027C2
Method for designing, controlling and applying macromolecule associates and complex aggregates with increased useful loading and controlled association/dissociation degree
US6165500A
Preparation for the application of agents in mini-droplets
